Advocacy group questions Medanta MD Naresh Trehan’s inclusion in panel on pharma marketing practices
An Indian advocacy group has written to the Department of Pharmaceuticals asking that Dr. Naresh Trehan, chairman of Medanta, be removed from a government panel overseeing pharmaceutical marketing practices. The group argues his position creates a conflict of interest and recommends appointing a member without such ties. The request seeks to ensure impartial oversight of industry marketing standards.